At a glance
- Originator Central Drug Research Institute
- Class Antiallergics; Antiasthmatics; Quinazolines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypersensitivity
Most Recent Events
- 19 Oct 1998 No-Development-Reported for Allergy in India (Unknown route)
- 22 May 1995 Phase-II clinical trials for Allergy in India (Unknown route)